(Q24337730)

2

0 references

X Qin

3

0 references

D Ye

4

0 references

Z Yi

5

0 references

M Liu

6

0 references

O Bai

7

0 references

W Liu

8

0 references

X Xie

9

0 references

Z Wang

10

0 references

J Fang

11

0 references

Y Chen

Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer

12

0 references

language of work or name

English

0 references

publication date

30 September 2010

0 references

published in

Oncogene

0 references

volume

29

0 references

issue

39

0 references

page(s)

5404-15

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Role of Raf in vascular protection from distinct apoptotic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

An essential role for p300/CBP in the cellular response to hypoxia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Sorafenib in advanced clear-cell renal-cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Spatial regulation of Raf kinase signaling by RKTG

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Vascular endothelial growth factor: basic science and clinical progress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Both v-Ha-Ras and v-Raf Stimulate Expression of the Vascular Endothelial Growth Factor in NIH 3T3 Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Tumour suppression by the human von Hippel-Lindau gene product

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Autocrine VEGF signaling is required for vascular homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Sorafenib in advanced hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

VEGFs and receptors involved in angiogenesis versus lymphangiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Characterization of the topology and functional domains of RKTG.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1alpha.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Spred is a Sprouty-related suppressor of Ras signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Suppressive function of RKTG on chemical carcinogen-induced skin carcinogenesis in mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270

Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.270